Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)

VL Lazarevic; M Labopin; D P Wu; I Yakoub-Agha; A Huynh; P Ljungman; N Schaap; Jan Cornelissen; N Maillard; P Pioltelli; T Gedde-Dahl; S Lenhoff; M Houhou; J Esteve; M Mohty; A Nagler

doi:10.1002/ajh.24928

Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)

VL Lazarevic
, M Labopin
, D P Wu
, I Yakoub-Agha
, A Huynh
, P Ljungman
, N Schaap
, Jan Cornelissen
, N Maillard
, P Pioltelli
, T Gedde-Dahl
, S Lenhoff
, M Houhou
, J Esteve
, M Mohty
, A Nagler

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

16 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	31-39
Number of pages	9
Journal	American Journal of Hematology
Volume	93
Issue number	1
DOIs	https://doi.org/10.1002/ajh.24928
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1002/ajh.24928

http://hdl.handle.net/1765/102817

Cite this

Lazarevic, VL., Labopin, M., Wu, D. P., Yakoub-Agha, I., Huynh, A., Ljungman, P., Schaap, N., Cornelissen, J., Maillard, N., Pioltelli, P., Gedde-Dahl, T., Lenhoff, S., Houhou, M., Esteve, J., Mohty, M., & Nagler, A. (2018). Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT). American Journal of Hematology, 93(1), 31-39. https://doi.org/10.1002/ajh.24928

@article{c1c19de0ba0e4493a844244fcbfd8845,

title = "Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)",

author = "VL Lazarevic and M Labopin and Wu, \{D P\} and I Yakoub-Agha and A Huynh and P Ljungman and N Schaap and Jan Cornelissen and N Maillard and P Pioltelli and T Gedde-Dahl and S Lenhoff and M Houhou and J Esteve and M Mohty and A Nagler",

year = "2018",

doi = "10.1002/ajh.24928",

language = "Undefined/Unknown",

volume = "93",

pages = "31--39",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "John Wiley \& Sons Inc.",

number = "1",

}

Lazarevic, VL, Labopin, M, Wu, DP, Yakoub-Agha, I, Huynh, A, Ljungman, P, Schaap, N, Cornelissen, J, Maillard, N, Pioltelli, P, Gedde-Dahl, T, Lenhoff, S, Houhou, M, Esteve, J, Mohty, M & Nagler, A 2018, 'Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)', American Journal of Hematology, vol. 93, no. 1, pp. 31-39. https://doi.org/10.1002/ajh.24928

Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT). / Lazarevic, VL; Labopin, M; Wu, D P et al.
In: American Journal of Hematology, Vol. 93, No. 1, 2018, p. 31-39.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)

AU - Lazarevic, VL

AU - Labopin, M

AU - Wu, D P

AU - Yakoub-Agha, I

AU - Huynh, A

AU - Ljungman, P

AU - Schaap, N

AU - Cornelissen, Jan

AU - Maillard, N

AU - Pioltelli, P

AU - Gedde-Dahl, T

AU - Lenhoff, S

AU - Houhou, M

AU - Esteve, J

AU - Mohty, M

AU - Nagler, A

PY - 2018

Y1 - 2018

U2 - 10.1002/ajh.24928

DO - 10.1002/ajh.24928

M3 - Article

C2 - 28971504

SN - 0361-8609

VL - 93

SP - 31

EP - 39

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 1

ER -